TNF Pharmaceuticals, Inc. (LON:0A8D)
London
· Delayed Price · Currency is GBP · Price in USD 0.545
-0.022 (-3.84%)
At close: Feb 14, 2025
TNF Pharmaceuticals Employees
TNF Pharmaceuticals had 6 employees as of December 31, 2023. The number of employees decreased by 3 or -33.33% compared to the previous year.
Employees
6
Change (1Y)
-3
Growth (1Y)
-33.33%
Revenue / Employee
n/a
Profits / Employee
-3.60M GBP
Market Cap
1.04M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 6 | -3 | -33.33% |
| Dec 31, 2022 | 9 | 0 | - |
| Dec 31, 2021 | 9 | 3 | 50.00% |
| Dec 31, 2020 | 6 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 89,900 |
| Shell | 103,000 |
| HSBC Holdings | 220,861 |
| Unilever | 128,377 |
| Rio Tinto Group | 57,000 |
| RELX PLC | 36,400 |
| BP p.l.c. | 87,800 |
| British American Tobacco p.l.c. | 46,725 |
TNF Pharmaceuticals News
- 9 days ago - Aker outlines 5% dividend growth for Aker BP in 2025 amid strong cash flow and portfolio streamlining - Seeking Alpha
- 4 years ago - Akers Biosciences and MyMD Pharmaceuticals Announce Stockholder Approval of Merger - Business Wire
- 4 years ago - Akers' Proposed Merger Partner MyMD Pharmaceuticals Announces Plans to Initiate COVID-19 Inflammatory Depression Trial - Business Wire
- 4 years ago - Akers' Proposed Merger Partner MyMD Pharmaceuticals Announces Formation of Scientific Advisory Board - Business Wire
- 4 years ago - Akers Biosciences Announces Shareholder Meeting to Vote on Business Combination with MyMD Pharmaceuticals - Business Wire
- 4 years ago - SHAREHOLDER ALERT: WeissLaw LLP Reminds NTWN, TLRY, CBLI, and AKER Shareholders About Its Ongoing Investigations - PRNewsWire
- 4 years ago - Akers Biosciences' Proposed Partner MyMD's Lead Candidate Inhibits Fibrotic Diseases-Associated Biomarkers - Benzinga
- 4 years ago - MyMD Pharmaceuticals Announces New Data on Its Lead Compound MYMD-1 from a Phenotypic Study Performed by Eurofins Discovery - Business Wire